HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

502U83

Subscribe to New Research on 502U83

an arylmethylaminopropanediol; structure given in first source

Also Known As:

BW 502U83; BW-502U83; BW502U83

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 58
- Hydrocarbons: 412
  - Cyclic Hydrocarbons: 3
    - Aromatic Hydrocarbons: 132
      - Aromatic Polycyclic Hydrocarbons: 831
        Anthracenes: 16
        502U83: 2
Polycyclic Compounds: 56
- Aromatic Polycyclic Hydrocarbons: 831
  - Anthracenes: 16
    - 502U83: 2

Related Diseases

1.	Neoplasms (Cancer) 06/01/1992 - "Phase I and pharmacokinetic study of 502U83 (an arylmethylaminopropanediol) in cancer patients." 12/01/1990 - "502U83 is an arylmethylaminopropanediol derivative exhibiting significant antineoplastic activity in a number of murine and human tumor models. " 06/01/1992 - "502U83, a novel arylmethylaminopropanediol, has proven active in vivo against a panel of murine leukemia and solid tumors as well as in a tumor clonogenic assay against a variety of fresh human cancers. "
2.	Leukemia 06/01/1992 - "502U83, a novel arylmethylaminopropanediol, has proven active in vivo against a panel of murine leukemia and solid tumors as well as in a tumor clonogenic assay against a variety of fresh human cancers. "